NEW YORK, June 15, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for CLVS, REV, SNDL, XPEV, and NILE.

InvestorsObserver (PRNewsfoto/InvestorsObserver)

To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link.

  • CLVS: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?symbol=CLVS&prnumber=061520221 
  • REV: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?symbol=REV&prnumber=061520221 
  • SNDL: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?symbol=SNDL&prnumber=061520221 
  • XPEV: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?symbol=XPEV&prnumber=061520221 
  • NILE: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?symbol=NILE&prnumber=061520221 

(Note: You may have to copy this link into your browser then press the [ENTER] key.)

InvestorsObserver's PriceWatch Alerts are based on our proprietary scoring methodology. Each stock is evaluated based on short-term technical, long-term technical and fundamental factors. Each of those scores is then combined into an overall score that determines a stock's overall suitability for investment.

InvestorsObserver provides patented technology to some of the biggest names on Wall Street and creates world-class investing tools for the self-directed investor on Main Street. We have a wide range of tools to help investors make smarter decisions when investing in stocks or options.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/thinking-about-buying-stock-in-clovis-oncology-revlon-sundial-growers-xpeng-or-bitnile-301568581.html

SOURCE InvestorsObserver